| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CytomX Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 38,000 | 11 Jun 2025 | Direct | ||
| NextCure, Inc. | Director | Stock Option (Right to Buy) | 18,700 | 20 Jun 2025 | Direct | ||
| Gritstone bio, Inc. | Director | Stcok Option (right to buy) | 0 | 04 Apr 2025 | Direct | ||
| Gritstone bio, Inc. | Director | Stock Option (Right to Buy) | 0 | 04 Apr 2025 | Direct |